Adrian Ion-Margineanu1,2, Sofie Van Cauter3,4, Diana M Sima1,2, Frederik Maes2,5, Stefan Sunaert3, Stefaan Van Gool6, Uwe Himmelreich7, and Sabine Van Huffel1,2
1ESAT - STADIUS, KU Leuven, Leuven, Belgium, 2Medical IT, iMinds, Leuven, Belgium, 3Department of Radiology, University Hospitals of Leuven, Leuven, Belgium, 4ZOL - Ziekenhuis Oost-Limburg, Genk, Belgium, 5ESAT - PSI, KU Leuven, Leuven, Belgium, 6Department of Pedriatic Neuro-Oncology, University Hospitals of Leuven, Leuven, Belgium, 7Department of Imaging and Pathology, Biomedical MRI / MoSAIC, Leuven, Belgium
Synopsis
Delineating
contrast enhancing (CE) tissue is an integral part of the RANO criteria for
therapy response assessment in high-grade gliomas. We propose a semi-automatic
delineation of hotspots of CE (HCE) in brain tumour follow-up of 29 glioblastoma
multiforme patients after surgery. Based on multi-parametric magnetic resonance
data we predict the post-operative evolution of the brain tumour by labelling
each patient at each time point as responsive or progressive. The results
obtained with our semi-automatic method are better in most of the cases than the
results obtained with the original manual delineations. Moreover, our method
can efficiently impute missing data.Purpose
Delineating
contrast enhancing (CE) tissue is an integral part of the RANO criteria for
therapy response assessment in high-grade gliomas. Manual delineations of brain
tumours provide an approximate separation between the CE region of interest
(ROI) and perilesional edema (ED) ROI. The focus of this study is to evaluate
the impact of semi-automatic delineation of hotspots of CE (HCE) in brain
tumour follow-up of glioblastoma multiforme (GBM) patients after surgery. Based
on multi-parametric magnetic resonance data we predict the post-operative evolution
of the brain tumour by labelling each patient at each time point as responsive
or progressive. We compare the results obtained with our semi-automatic method
to the results obtained with the original manual delineations.
Methods
Acquisition
Twenty-nine
GBM patients who underwent surgery were scanned monthly using a 3 Tesla MRI
unit (Philips Achieva, Best, The Netherlands). One scanning session consisted of conventional
MRI (T1-weighted MRI before and after contrast administration, T2-weighted MRI
and FLAIR (fluid attenuated inversion recovery) MRI) and advanced MRI (diffusion
kurtosis imaging (DKI), dynamic-susceptibility weighted contrast (DSC) - MRI). ROIs
were manually drawn on the T1-post contrast (T1pc) images by an expert
radiologist around the solid CE region and the entire
lesion (TO), i.e. CE and ED. Another ROI was drawn around the contralateral
normal appearing white matter (NAWM) to standardize the hemodynamic
measurements of DSC-MRI 1. A label (responsive or progressive) has been put on
each patient at a certain time point (TP0) according to the RANO criteria.
Proposed method
We
create another set of ROIs in the following way: for each session of each
patient we take the T1pc intensities of all manually delineated voxels (CE
& ED) and set an intensity threshold at the 90th percentile (P90). All the
voxels with intensities higher than or equal to P90 belong to the new HCE,
while the rest are labelled as extended ED (EED).
Feature extraction
After
processing DSC-MRI and DKI-MRI we have 8 perfusion maps and 7 diffusion maps,
respectively. To these we add the four conventional maps, so in total there are
19 parameter maps. For each patient session we perform an affine co-registration
of the parameter maps to the T1pc map. For each parameter map we normalize the intensities in each tumour ROI (CE, ED, HCE, EED) to the average value of the voxel intensities in the NAWM ROI. Within each tumour ROI (CE, ED, HCE, EED) we
compute the average, coefficient of variation, kurtosis, skewness, 10th
percentile and 90th percentile of the voxel intensities for each parameter map. In
total, from 29 patients, we have 43 data points, each with 228 features. The 43
data points correspond to a timeframe between TP0 and 6 months after TP0.
Results
We perform feature
selection on each set of ROIs (CE+ED vs. HCE+EED) by learning Random Forest
(RF) feature relevance on the training sets. Because we want to study the
impact of our new delineations compared to the manual delineations, we select a
common set of five features that have high relevance for the two sets of ROIs
(table 1).
By
using our approach as an imputation method, we add 12 points to the dataset,
using only CE or ED as starting delineation, not the reunion CE&ED, as described
in Methods. We keep the same 5
features. We test 4 classifiers (Support Vector Machines
(SVM), Linear Discriminant Analysis (LDA), RUSBoost and Bagging) using Leave
One Patient Out Cross Validation (LOPO-CV). We measure performance by computing
the balanced error rate (BER) for each time point and the weighted BER (wBER)
for all time points. 2
Discussion
Automatic
feature selection revealed that (H)CE provides the most important features. The
classification results using our semi-automatic delineations are better in
almost all cases (table 2) compared to those using the manual delineations. Most
of the 12 added points did not have a manual CE ROI because the expert did not
see any enhancing tissue, most likely due to the fact that all 12 points are
labelled as responsive. After imputing features using our approach, we notice a
significant decrease in wBER for all classifiers. This is mostly due to a
better learning stage of the classifiers, because now the responsive class has 12
more data points (table 3).
Conclusion
Our
new semi-automatic delineation method provides a better classification between
responsive and progressive patients and can efficiently be used to impute
missing features.
Acknowledgements
This work has been funded by the following projects: Flemish Government FWO project G.0869.12N (Tumor imaging); Belgian Federal Science Policy Oce: IUAP P7/19/ (DYSCO, `Dynamical systems,control and optimization', 2012-2017); EU: The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programe (FP7/2007-2013).This paper reflects only the authors' views and the Union is not liable for any use that may be made of the contained information. Other EU funding: EU MC ITN TRANSACT 2012 (no. 316679)References
1. Sofie V C et al. Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical
shift imaging for grading gliomas. Neuro Oncol (2014). 16 (7): 1010-1021
2. Adrian I-M et al. Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients. BioMed Research International. vol. 2015. Article ID 842923.